Antigen presentation at the inflammatory site
- PMID: 2679663
Antigen presentation at the inflammatory site
Abstract
The introduction of antigen into tissues can induce an inflammatory response initiated by antigen-specific T lymphocytes. Central to this process is the recognition of antigen by specific T cells that cannot respond to intact antigen directly, but rather recognize antigenic fragments in association with gene products of the major histocompatibility complex (MHC) displayed by an antigen-presenting cell. To present antigen effectively, a cell must internalize antigen, process it to the immunogenic moiety, present the antigen in the context of a MHC molecule, and deliver various antigen-nonspecific signals required for T-cell activation. At the initiation of an immune response, the cells with the capacity to perform all of these functions are limited to a few specialized cell types, including monocytes/macrophages, dendritic cells, B cells, and Langerhans cells. Once the immune response has been initiated, however, cytokines and other factors, released by activated cells at the inflammatory site, stimulate a variety of changes in various cell types that alter their capacity to function as antigen-presenting cells and facilitate antigen-induced T-cell activation. Therefore, as the immunologically mediated inflammatory response evolves, a variety of changes occur within the local environment that enhance and/or modulate the capacity of T cells to recognize and respond to the inciting antigen. The purpose of this review is to catalog the changes in the function of antigen-presenting cells at inflammatory sites that might alter the nature of the immune response.
Similar articles
-
Antigen presentation by cells that are not of bone marrow origin.Reg Immunol. 1989 Jan-Feb;2(1):60-71. Reg Immunol. 1989. PMID: 2518360 Review.
-
The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation.Invest Ophthalmol Vis Sci. 1997 Nov;38(12):2662-71. Invest Ophthalmol Vis Sci. 1997. PMID: 9375586
-
Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.J Immunol. 1985 Dec;135(6):3750-62. J Immunol. 1985. PMID: 3934267
-
Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.In Vivo. 1997 Jul-Aug;11(4):351-70. In Vivo. 1997. PMID: 9292303
-
Antigen presenting cells and mechanisms of antigen presentation.Crit Rev Immunol. 1985;5(3):263-316. Crit Rev Immunol. 1985. PMID: 3884274 Review.
Cited by
-
Immunologic environment influences macrophage response to Porphyromonas gingivalis.Mol Oral Microbiol. 2017 Jun;32(3):250-261. doi: 10.1111/omi.12168. Epub 2016 Aug 26. Mol Oral Microbiol. 2017. PMID: 27346827 Free PMC article.
-
Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives.J Microbiol. 2014 Mar;52(3):211-26. doi: 10.1007/s12275-014-4068-2. Epub 2014 Mar 1. J Microbiol. 2014. PMID: 24585052 Review.
-
Raf-1 is required for T cell IL2 production.EMBO J. 1993 Nov;12(11):4367-73. doi: 10.1002/j.1460-2075.1993.tb06121.x. EMBO J. 1993. PMID: 8223446 Free PMC article.
-
Evidence of CXC, CC and C chemokine production by lymphatic endothelial cells.Immunology. 2003 Apr;108(4):523-30. doi: 10.1046/j.1365-2567.2003.01613.x. Immunology. 2003. PMID: 12667214 Free PMC article.
-
Swine leukocyte antigen and macrophage marker expression on both African swine fever virus-infected and non-infected primary porcine macrophage cultures.Vet Immunol Immunopathol. 1992 May;32(3-4):243-59. doi: 10.1016/0165-2427(92)90049-v. Vet Immunol Immunopathol. 1992. PMID: 1632065 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials